Physician profile
Amber Johnson
NPI 1982467650
$1,999.25
in general payments reported to CMS, 2019-2025
17 companies · $1,857 in 2025
The $1,857 reported for 2025 was more than what 91% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $142 · 2025: $1,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.97 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $386.37 | 2024-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $283.90 | 2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $207.01 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $138.96 | 2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $91.14 | 2024-2025 | Rexulti |
| Tris Pharma INC | $90.11 | 2025 | Dyanavel Xr |
| Noven Therapeutics, LLC | $82.74 | 2024-2025 | Xelstrym, Secuado |
| Janssen Pharmaceuticals, INC | $77.54 | 2024-2025 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $55.09 | 2025 | Cobenfy |
| Almatica Pharma LLC | $38.81 | 2024-2025 | Loreev Xr |
| Inspire Medical Systems, INC. | $37.65 | 2025 | Inspire |
| Collegium Pharmaceutical, INC. | $22.08 | 2025 | Jornay Pm |
| Harmony Biosciences LLC | $18.23 | 2025 | |
| Neos Therapeutics, LP | $15.25 | 2025 | Adzenys Xr-Odt |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.25 | 2025 | Trintellix |
| Exact Sciences Corporation | $13.15 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.